Product Description
Methenamine, an antibiotic, eliminates bacteria that cause urinary tract infections. It usually is used on a long-term basis to treat chronic infections and to prevent recurrence of infections. Antibiotics will not work for colds, flu, or other viral infections. (Sourced from: https://medlineplus.gov/druginfo/meds/a682296.html)
Mechanisms of Action: Bacterial Growth Inhibitor,Protein Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: None *
Approval Status: Approved
Approved Countries: Argentina | Australia | Bangladesh | Belgium | Brazil | Canada | Chile | China | Colombia | Denmark | Ecuador | Egypt | Finland | Hong Kong | Iceland | India | Indonesia | Ireland | Malaysia | Mexico | New Zealand | Norway | Pakistan | Portugal | Russia | South Africa | Sweden | Taiwan | Turkey | United Kingdom | United States | Venezuela
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|